PNC Financial Services Group’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
Other funds holding PRME
PNC Financial Services Group's PRME Position: Q3 2026 in Review
PNC Financial Services Group sold out of Prime Medicine (PRME) in Q3 2026, closing a stake of 319 shares — an estimated $1.18K sold.
PNC Financial Services Group first reported a position in PRME in Q2 2024 and held it in 9 quarters. The position peaked at $1.77K in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q3 2026.
- PNC Financial Services Group reported no remaining Prime Medicine position as of Q3 2026 after selling out during the quarter.
- PNC Financial Services Group sold 319 Prime Medicine shares in Q3 2026, an estimated $1.18K.
- PNC Financial Services Group first reported a position in Prime Medicine in Q2 2024 and held it in 9 quarters.
- PNC Financial Services Group's Prime Medicine position peaked at $1.77K in Q3 2025.
- 187 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.